Aniza Mohammed Jelani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aniza Mohammed Jelani has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Julia Omar
Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
2 shared publications Najib Majdi Yaacob
Unit of Biostatistics and Research Methodology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kelantan, Malaysia
2 shared publications- Najib Majdi Yaacob
Units of Biostatistics and Research Methodology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia
2 shared publications - Noorazliyana Shafii
Affiliation Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
2 shared publications - Wan Norlina Wan Azman
Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia.
2 shared publications A A Razak
Universiti Sains Malaysia, School of Medical Sciences, Department of Chemical Pathology, Health Campus, Kota Bharu, Kelantan, Malaysia
1 shared publication
Latest Publications
- 1 November 2025
- Vol. 80 (6) , 868-873
Evaluation of analytical performance of Sebia Capillarys 3 Octa electrophoresis method for serum protein electrophoresis.
Protein electrophoresis is a crucial test in clinical diagnostic laboratory, aimed for evaluation of plasma protein distribution. With its capability for highresolution protein separation, rapid analysis and automated features, capillary electrophoresis (CE) has emerged as a valuable alternative to the traditional gel-based methods that are widely used in our country. This study aimed to evaluate the analytical performance of Sebia Capillary 3 Octa CE system in our laboratory setting. The study was conducted at the Protein Diagnostic Laboratory, Hospital Pakar Universiti Sains Malaysia. Within-run and between run precision was assessed using Sebia Capillarys 3 Octa CE system with commercially available normal and pathological control sera. Accuracy was evaluated by comparing results from the Sebia Capillarys 3 Octa with those from the Sebia Hydrasys 2 Scan gel electrophoresis analyzer using both healthy and patient serum samples. Reference interval verification involved testing serum from healthy volunteers. Statistical analyses included mean, standard deviation, coefficient of variation (CV), linear regression, and Bland-Altman analysis. Sebia Capillarys 3 Octa demonstrated good precision across all serum protein fractions, with within-run CVs for normal serum ranging from 0.97% (albumin) to 7.04% (alpha-1), and between-run CVs below 7.22%. Pathological serum showed CVs from 0.60% (gamma) to 5.09% (alpha-1), and from 0.89% (albumin) to 10.32% (alpha- 2) for within-run and between run CV, respectively. CE correlated strongly with gel electrophoresis for albumin and gamma globulin (r > 0.95), with alpha 1, alpha2 and beta showed good correlation (r >0.80) between the two methods. There was minimal bias (-1.1 to +2.1) noted. Reference interval verification confirmed compatibility with manufacturer-provided ranges. Sebia Capillarys 3 Octa provides reliable, automated analysis for serum protein fractions, offering performance comparable to the conventional agarose gel electrophoresis analyzer with enhanced operational benefits for routine laboratory use.
- 1 November 2025
- Vol. 80 (6) , 868-873
Evaluation of analytical performance of Sebia Capillarys 3 Octa electrophoresis method for serum protein electrophoresis.
Protein electrophoresis is a crucial test in clinical diagnostic laboratory, aimed for evaluation of plasma protein distribution. With its capability for highresolution protein separation, rapid analysis and automated features, capillary electrophoresis (CE) has emerged as a valuable alternative to the traditional gel-based methods that are widely used in our country. This study aimed to evaluate the analytical performance of Sebia Capillary 3 Octa CE system in our laboratory setting. The study was conducted at the Protein Diagnostic Laboratory, Hospital Pakar Universiti Sains Malaysia. Within-run and between run precision was assessed using Sebia Capillarys 3 Octa CE system with commercially available normal and pathological control sera. Accuracy was evaluated by comparing results from the Sebia Capillarys 3 Octa with those from the Sebia Hydrasys 2 Scan gel electrophoresis analyzer using both healthy and patient serum samples. Reference interval verification involved testing serum from healthy volunteers. Statistical analyses included mean, standard deviation, coefficient of variation (CV), linear regression, and Bland-Altman analysis. Sebia Capillarys 3 Octa demonstrated good precision across all serum protein fractions, with within-run CVs for normal serum ranging from 0.97% (albumin) to 7.04% (alpha-1), and between-run CVs below 7.22%. Pathological serum showed CVs from 0.60% (gamma) to 5.09% (alpha-1), and from 0.89% (albumin) to 10.32% (alpha- 2) for within-run and between run CV, respectively. CE correlated strongly with gel electrophoresis for albumin and gamma globulin (r > 0.95), with alpha 1, alpha2 and beta showed good correlation (r >0.80) between the two methods. There was minimal bias (-1.1 to +2.1) noted. Reference interval verification confirmed compatibility with manufacturer-provided ranges. Sebia Capillarys 3 Octa provides reliable, automated analysis for serum protein fractions, offering performance comparable to the conventional agarose gel electrophoresis analyzer with enhanced operational benefits for routine laboratory use.
- Open Access
- 18 May 2024
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-15
Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis
Background: Epidemiological studies regarding the correlation between anti-Müllerian hormone (AMH) and insulin resistance (IR) in polycystic ovarian syndrome (PCOS) remain inconsistent. The primary aim of this study was to determine the correlations between AMH and IR in patients with PCOS and to explore the selected factors that influence the correlations. Methods: We conducted systemic searches of online databases (PubMed, Science Direct, Taylor and Francis, Scopus, and ProQuest) from inception to December 20, 2023 and manual searches of the associated bibliographies to identify relevant studies. We then performed subgroup and sensitivity analyses to explore the sources of heterogeneity, followed by a publication bias risk assessment of the included studies using the Joanna Briggs Institute critical appraisal tool. We used a random-effects model to estimate the pooled correlations between AMH and the homeostatic model assessment for insulin resistance (HOMA-IR) in patients with polycystic ovarian syndrome (PCOS). Results: Of the 4835 articles identified, 22 eligible relevant studies from three regions were included and identified as low risk of bias. The random-effects pooled correlation estimate was 0.089 (95% confidence interval [CI]: −0.040, 0.215), with substantial heterogeneity (I2 = 87%; τ2 = 0.0475, p < .001). Subgroup analyses showed that the study region did not influence the correlation estimates, and sensitivity analysis showed no significant alteration in the pooled correlation estimate or 95% CI values. No publication bias was observed. Conclusion: There was a weak, statistically insignificant correlation between AMH and HOMA-IR in patients with PCOS. The correlation estimates did not vary according to the study participants’ regions.
- 18 May 2024
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-15
Open AccessCorrelation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis
Background: Epidemiological studies regarding the correlation between anti-Müllerian hormone (AMH) and insulin resistance (IR) in polycystic ovarian syndrome (PCOS) remain inconsistent. The primary aim of this study was to determine the correlations between AMH and IR in patients with PCOS and to explore the selected factors that influence the correlations. Methods: We conducted systemic searches of online databases (PubMed, Science Direct, Taylor and Francis, Scopus, and ProQuest) from inception to December 20, 2023 and manual searches of the associated bibliographies to identify relevant studies. We then performed subgroup and sensitivity analyses to explore the sources of heterogeneity, followed by a publication bias risk assessment of the included studies using the Joanna Briggs Institute critical appraisal tool. We used a random-effects model to estimate the pooled correlations between AMH and the homeostatic model assessment for insulin resistance (HOMA-IR) in patients with polycystic ovarian syndrome (PCOS). Results: Of the 4835 articles identified, 22 eligible relevant studies from three regions were included and identified as low risk of bias. The random-effects pooled correlation estimate was 0.089 (95% confidence interval [CI]: −0.040, 0.215), with substantial heterogeneity (I2 = 87%; τ2 = 0.0475, p < .001). Subgroup analyses showed that the study region did not influence the correlation estimates, and sensitivity analysis showed no significant alteration in the pooled correlation estimate or 95% CI values. No publication bias was observed. Conclusion: There was a weak, statistically insignificant correlation between AMH and HOMA-IR in patients with PCOS. The correlation estimates did not vary according to the study participants’ regions.
- Open Access
- 6 November 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 8199
Global Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis
Hyperprolactinemia (hPRL) often poses a diagnostic dilemma due to the presence of macroprolactin. Understanding the prevalence of macroprolactinemia (mPRL) has an important implication in managing patients with hPRL. The primary aim of this study was to determine the prevalence of mPRL globally and to explore selected factors influencing the prevalence estimate. Studies with original data related to the prevalence of mPRL among patients with hPRL from inception to March 2020 were identified, and a random effects meta-analysis was performed. Of the 3770 records identified, 67 eligible studies from 27 countries were included. The overall global prevalence estimate was 18.9% (95% CI: 15.8%, 22.1%) with a substantial statistical heterogeneity (I2 = 95.7%). The highest random effects pooled prevalence was observed in the African region (30.3%), followed by Region of the Americas (29.1%), European (17.5%), Eastern Mediterranean (13.9%), South-East Asian (12.7%), and Western Pacific Region (12.6%). Lower prevalence was observed in studies involving both sexes as compared to studies involving only female participants (17.1% vs. 25.4%) and in more recent studies (16.4%, 20.4%, and 26.5% in studies conducted after 2009, between 2000 and 2009, and before 2000, respectively). The prevalence estimate does not vary according to the age group of study participants, sample size, and types of polyethylene glycol (PEG) used for detection of macroprolactin (PEG 6000 or PEG 8000). With macroprolactin causing nearly one-fifth of hPRL cases, screening for mPRL should be made a routine before an investigation of other causes of hPRL.
- 6 November 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 8199
Open AccessGlobal Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis
Hyperprolactinemia (hPRL) often poses a diagnostic dilemma due to the presence of macroprolactin. Understanding the prevalence of macroprolactinemia (mPRL) has an important implication in managing patients with hPRL. The primary aim of this study was to determine the prevalence of mPRL globally and to explore selected factors influencing the prevalence estimate. Studies with original data related to the prevalence of mPRL among patients with hPRL from inception to March 2020 were identified, and a random effects meta-analysis was performed. Of the 3770 records identified, 67 eligible studies from 27 countries were included. The overall global prevalence estimate was 18.9% (95% CI: 15.8%, 22.1%) with a substantial statistical heterogeneity (I2 = 95.7%). The highest random effects pooled prevalence was observed in the African region (30.3%), followed by Region of the Americas (29.1%), European (17.5%), Eastern Mediterranean (13.9%), South-East Asian (12.7%), and Western Pacific Region (12.6%). Lower prevalence was observed in studies involving both sexes as compared to studies involving only female participants (17.1% vs. 25.4%) and in more recent studies (16.4%, 20.4%, and 26.5% in studies conducted after 2009, between 2000 and 2009, and before 2000, respectively). The prevalence estimate does not vary according to the age group of study participants, sample size, and types of polyethylene glycol (PEG) used for detection of macroprolactin (PEG 6000 or PEG 8000). With macroprolactin causing nearly one-fifth of hPRL cases, screening for mPRL should be made a routine before an investigation of other causes of hPRL.
- Open Access
- 1 January 2020
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 24 (2) , 191-195
Serum Anti-Müllerian hormone in polycystic ovary syndrome and its relationship with insulin resistance, lipid profile and adiponectin
Objectives: This study was done to estimate serum anti-Müllerian hormone (AMH) level in polycystic ovary syndrome (PCOS) patients and to correlate serum AMH level with insulin resistance, lipid profile, and adiponectin levels. Materials and Methods: A cross-sectional study was conducted at Hospital Universiti Sains Malaysia (Hospital USM), Health Campus, Kubang Kerian, Kelantan, Malaysia. Thirty newly diagnosed patients with PCOS attending gynecology clinic between July 2016 and April 2017 were recruited. Fasting venous blood samples were collected from the subjects. Serum AMH, insulin, adiponectin, triglycerides, high-density lipoprotein cholesterol (HDL-C), and plasma glucose levels were measured, and insulin resistance was calculated based on homeostasis model of assessment-insulin resistance (HOMA-IR). The serum AMH level was estimated, and the correlation of serum AMH level with the metabolic parameters was analyzed. Results: The median of serum AMH levels in women with PCOS was 6.8 ng/mL (interquartile range: 7.38 ng/mL). There was a significant negative correlation between serum AMH and HOMA-IR or triglyceride levels (r = −0.49, P = 0.006 and r = −0.55, P = 0.002, respectively). A significant positive correlation was observed between serum AMH and serum HDL-C or serum adiponectin levels (r = 0.56, P = 0.001 and r = 0.44, P = 0.014, respectively) in all study subjects. Conclusion: The serum AMH level is associated with HOMA-IR, triglycerides, HDL-C, and adiponectin levels, and hence it may be used as a potential cardiometabolic risk marker in women with PCOS.
- 1 January 2020
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 24 (2) , 191-195
Open AccessSerum Anti-Müllerian hormone in polycystic ovary syndrome and its relationship with insulin resistance, lipid profile and adiponectin
Objectives: This study was done to estimate serum anti-Müllerian hormone (AMH) level in polycystic ovary syndrome (PCOS) patients and to correlate serum AMH level with insulin resistance, lipid profile, and adiponectin levels. Materials and Methods: A cross-sectional study was conducted at Hospital Universiti Sains Malaysia (Hospital USM), Health Campus, Kubang Kerian, Kelantan, Malaysia. Thirty newly diagnosed patients with PCOS attending gynecology clinic between July 2016 and April 2017 were recruited. Fasting venous blood samples were collected from the subjects. Serum AMH, insulin, adiponectin, triglycerides, high-density lipoprotein cholesterol (HDL-C), and plasma glucose levels were measured, and insulin resistance was calculated based on homeostasis model of assessment-insulin resistance (HOMA-IR). The serum AMH level was estimated, and the correlation of serum AMH level with the metabolic parameters was analyzed. Results: The median of serum AMH levels in women with PCOS was 6.8 ng/mL (interquartile range: 7.38 ng/mL). There was a significant negative correlation between serum AMH and HOMA-IR or triglyceride levels (r = −0.49, P = 0.006 and r = −0.55, P = 0.002, respectively). A significant positive correlation was observed between serum AMH and serum HDL-C or serum adiponectin levels (r = 0.56, P = 0.001 and r = 0.44, P = 0.014, respectively) in all study subjects. Conclusion: The serum AMH level is associated with HOMA-IR, triglycerides, HDL-C, and adiponectin levels, and hence it may be used as a potential cardiometabolic risk marker in women with PCOS.
- Open Access
- 25 March 2019
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 18 (2) , 233-237
Pre-operative serum total bilirubin level as an indicator marker of perforated appendicitis.
Objectives: Acute appendicitis is one of the most common surgical emergencies. Perforated appendicitis can result in increased morbidity and mortality. Thus, early identification of perforation can reduce the impact on patient and improve outcome. Apart from total white cell count (TWCC), serum total bilirubin (SB) has been shown to indicate perforation in appendicitis. The aim of this study was to assess the usefulness of serum total bilirubin (SB) as the preoperative indicator for perforated appendicitis. Materials and Methods: This was a retrospective study of all appendicectomies cases done in Hospital Universiti Sains Malaysia (HUSM) over a one-year period in 2014. Only patients with histopathologically confirmed appendicitis with available liver function tests and total white blood cell count preoperatively were included in the study. These appendicitis cases were further divided into perforated and non-perforated based on histopathological reports obtained. Results: A total of 245 patients had appendicectomy done in 2014 between January to December 2014. Out of 110 from these 245 patients met the inclusion and exclusion criteria. SB was significantly higher (p<0.001) in patients with perforated appendix compared to non-perforated. Conclusion: In conclusion, this study showed that preoperative SB is a useful laboratory parameter for perforated appendicitis to improve clinical decision-making by the clinician. Bangladesh Journal of Medical Science Vol.18(2) 2019 p.233-237
- 25 March 2019
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 18 (2) , 233-237
Open AccessPre-operative serum total bilirubin level as an indicator marker of perforated appendicitis.
Objectives: Acute appendicitis is one of the most common surgical emergencies. Perforated appendicitis can result in increased morbidity and mortality. Thus, early identification of perforation can reduce the impact on patient and improve outcome. Apart from total white cell count (TWCC), serum total bilirubin (SB) has been shown to indicate perforation in appendicitis. The aim of this study was to assess the usefulness of serum total bilirubin (SB) as the preoperative indicator for perforated appendicitis. Materials and Methods: This was a retrospective study of all appendicectomies cases done in Hospital Universiti Sains Malaysia (HUSM) over a one-year period in 2014. Only patients with histopathologically confirmed appendicitis with available liver function tests and total white blood cell count preoperatively were included in the study. These appendicitis cases were further divided into perforated and non-perforated based on histopathological reports obtained. Results: A total of 245 patients had appendicectomy done in 2014 between January to December 2014. Out of 110 from these 245 patients met the inclusion and exclusion criteria. SB was significantly higher (p<0.001) in patients with perforated appendix compared to non-perforated. Conclusion: In conclusion, this study showed that preoperative SB is a useful laboratory parameter for perforated appendicitis to improve clinical decision-making by the clinician. Bangladesh Journal of Medical Science Vol.18(2) 2019 p.233-237